Radiofrequency Ablation. Post-ablation Assessment Using CT Perfusion with Pharmacological Modulation in a Rat Subcutaneous Tumor Model

Academic Radiology

Volumn 16, Issue 3, 2009, Pages 321-331

  Wu, Hanping ^a   Exner, Agata A ^a   Krupka, Tianyi M ^a   Weinberg, Brent D ^a   Patel, Ravi ^a   Haaga, John R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

CT perfusion; postablation assessment; Radiofrequency ablation; tumor perfusion; vasoactive agents

Indexed keywords

HYDRALAZINE; IOVERSOL; OPTIRAY 240; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MEDICAL INSTRUMENTATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEEDLE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RAT; RECEIVER OPERATING CHARACTERISTIC; SHOULDER; SUBCUTANEOUS TISSUE; SUBCUTANEOUS TISSUE TUMOR; TUMOR BLOOD FLOW; TUMOR DIAGNOSIS; TUMOR MODEL; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; DISEASE MODELS, ANIMAL; HUMANS; IMAGE ENHANCEMENT; MALE; NEOPLASMS, EXPERIMENTAL; PROGNOSIS; RATS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 59449087072     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.09.008     Document Type: Article

References (29)

1. Hong K., Georgiades C.S., and Geschwind J.F. Technology insight: Image-guided therapies for hepatocellular carcinoma-intra-arterial and ablative techniques. Nat Clin Pract Oncol 3 (2006) 315-324
2. Gazelle G.S., McMahon P.M., Beinfeld M.T., Halpern E.F., and Weinstein M.C. Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology 233 (2004) 729-739
3. Harrison L.E., Koneru B., Baramipour P., et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 197 (2003) 759-764
4. Curley S.A. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol 15 (2008) 11-13
5. Lim H.K., Choi D., Lee W.J., et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 221 (2001) 447-454
6. Lu D.S., Yu N.C., Raman S.S., et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234 (2005) 954-960
7. Lencioni R., Cioni D., and Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 26 (2001) 345-360
8. Veit P., Antoch G., Stergar H., Bockisch A., Forsting M., and Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16 (2006) 80-87
9. Okuma T., Okamura T., Matsuoka T., et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20 (2006) 115-121
10. Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R.K., and McDonald D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160 (2002) 985-1000
11. Baluk P., Morikawa S., Haskell A., Mancuso M., and McDonald D.M. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163 (2003) 1801-1815
12. Ekelund L. Pharmacoangiography of the kidney: an overview. Urol Radiol 2 (1980) 9-15
13. Miles K.A., Griffiths M.R., and Perfusion C.T. a worthwhile enhancement?. Br J Radiol 76 (2003) 220-231
14. Zima A., Carlos R., Gandhi D., Case I., Teknos T., and Mukherji S.K. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol 28 (2007) 328-334
15. Cuenod C.A., Leconte I., Siauve N., et al. Deconvolution technique for measuring tissue perfusion by dynamic CT: application to normal and metastatic liver. Acad Radiol 9 suppl (2002) S205-S211
16. Krupka T.M., Weinberg B.D., Wu H., Ziats N.P., and Exner A.A. Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats. Exp Biol Med (Maywood) 232 (2007) 950-957
17. Tozer G.M., Maxwell R.J., Griffiths J.R., and Pham P. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. Br J Cancer 62 (1990) 553-560
18. Ohyama N., and Yamaguchi S. Effects of phenylephrine and prazosin on axial movement of the rat incisor and arterial blood pressure. Jpn J Pharmacol 80 (1999) 271-274
19. Goldberg S.N., Gazelle G.S., Compton C.C., Mueller P.R., and Tanabe K.K. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88 (2000) 2452-2463
20. Hsu C.P., Razavi M.K., So S.K., Parachikov I.H., and Benaron D.A. Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. J Vasc Interv Radiol 16 (2005) 1473-1478
21. Dromain C., de Baere T., Elias D., et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223 (2002) 255-262
22. Chaplin D.J., Acker B.D., and Horsman M.R. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy. Biomed Biochim Acta 48 (1989) S264-S268
23. Chan R.C., Babbs C.F., Vetter R.J., and Lamar C.H. Abnormal response of tumor vasculature to vasoactive drugs. J Natl Cancer Inst 72 (1984) 145-150
24. Bradley J.G. Nonprescription drugs and hypertension. Which ones affect blood pressure?. Postgrad Med 89 (1991) 195-197
25. Arce C., Segura-Pacheco B., Perez-Cardenas E., Taja-Chayeb L., Candelaria M., and Duennas-Gonzalez A. Hydralazine target: from blood vessels to the epigenome. J Transl Med 4 (2006) 10
26. Nielsen F.U., Topp S., Horsman M.R., Overgaard J., Stodkilde-Jorgensen H., and Maxwell R.J. Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction. NMR Biomed 12 (1999) 175-183
27. Phongkitkarun S., Kobayashi S., Kan Z., Lee T.Y., and Charnsangavej C. Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats. Acad Radiol 11 (2004) 573-582
28. Lassau N., Chami L., Benatsou B., Peronneau P., and Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol 17 suppl (2007) F89-F98
29. Bisdas S., Medov L., Baghi M., et al. A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol 18 (2008) 843-850